What Is Paxlovid For? Uses, Risks, and Who Qualifies

Paxlovid is a prescription antiviral treatment for mild-to-moderate COVID-19 in adults who are at high risk of becoming seriously ill. It combines two medications into a five-day course of pills designed to stop the virus from replicating inside your body. The FDA approved it specifically to reduce the chances of hospitalization or death in people whose age or health conditions make severe COVID-19 more likely.

Who Qualifies for Paxlovid

Paxlovid isn’t meant for everyone who catches COVID-19. It’s targeted at adults with at least one risk factor for severe disease. Those risk factors include diabetes, being overweight (a BMI above 25), chronic lung disease (including asthma), chronic kidney disease, cardiovascular disease, high blood pressure, active cancer, a weakened immune system (from a condition or from medications like chemotherapy), sickle cell disease, neurodevelopmental disorders, and current smoking.

If you’re 60 or older, you qualify regardless of whether you have any other health conditions. Your doctor makes the call on whether the benefits outweigh the risks in your specific case, particularly because of Paxlovid’s long list of drug interactions.

How It Works

Each dose of Paxlovid contains two separate drugs working together. The first blocks a key enzyme the virus needs to copy itself. Without that enzyme, the virus can’t process the raw protein materials it needs to assemble new viral particles, so replication stalls. The second drug doesn’t fight the virus directly. Instead, it slows down your liver’s ability to break down the first drug, keeping blood levels high enough to be effective. Without this booster, your body would metabolize the antiviral component too quickly for it to work.

When to Start Treatment

Timing matters significantly with Paxlovid. It should be started within five days of your first symptoms. But research shows that starting even sooner makes a meaningful difference. A large study found that people who began treatment within one day of symptom onset or diagnosis had a 23% lower risk of hospitalization or death compared to those who started on day two or later. If you test positive and have risk factors, getting a prescription the same day gives you the best shot at a strong result.

What the Treatment Looks Like

The standard course is five days. Twice a day, you take three pills together: two pink tablets of the antiviral and one white tablet of the booster. That’s six pills total each day, 30 over the full course. If you have moderate kidney disease, your doctor will reduce the dose to one pink tablet plus one white tablet twice daily. People with severe kidney impairment may take an even further reduced schedule. Each dose should be taken about 12 hours apart, and you can take them with or without food.

Common Side Effects

The most talked-about side effect is an intensely bitter, metallic taste that many people call “Paxlovid mouth.” In postmarketing reports, about 17.5% of patients experienced this altered taste, and it was especially common in women. The taste can linger throughout the five-day course and sometimes for a few days after. Diarrhea, muscle aches, and high blood pressure have also been reported, though the taste disturbance is by far the most distinctive complaint. Side effects are generally mild and resolve after the treatment ends.

Drug Interactions Are a Major Concern

Because the booster component slows down a specific liver enzyme responsible for processing dozens of common medications, Paxlovid has one of the longest drug interaction lists of any antiviral. Some combinations are outright dangerous, while others require temporary dose changes or extra monitoring.

Medications you absolutely cannot take with Paxlovid include certain heart rhythm drugs, some seizure medications, specific cholesterol-lowering statins (lovastatin and simvastatin), certain sedatives, some migraine treatments, and the herbal supplement St. John’s Wort. These drugs either build up to toxic levels when the liver can’t clear them, or they reduce Paxlovid’s effectiveness so much that the treatment won’t work.

Other medications need adjustments rather than full stops. Blood thinners like warfarin, rivaroxaban, and apixaban may require closer monitoring. Blood pressure medications in the calcium channel blocker family, corticosteroids like fluticasone (a common inhaled steroid), immunosuppressants used after organ transplants, opioid pain medications, and certain antidepressants all need dose modifications during the five-day course. If you take any prescription medications, your pharmacist or doctor needs to review every one of them before you start Paxlovid.

Paxlovid Rebound

Some people feel better after finishing treatment, then experience a return of symptoms a few days later. This phenomenon, called Paxlovid rebound, typically shows up three to seven days after the initial illness resolves. It tends to be mild. In a large observational study, about 6.6% of people treated with Paxlovid experienced rebound, which was similar to the 4.5% rebound rate seen in people who received no antiviral treatment at all. Some other studies have reported higher rates, in the range of 10% to 14%.

When rebound happens, viral levels typically climb again around day nine after the original diagnosis and resolve by about day 16. No additional course of Paxlovid is recommended for rebound. The recurring symptoms usually pass on their own.

Cost and How to Get It

Paxlovid’s list price can be significant without assistance, but several programs reduce or eliminate out-of-pocket costs. Pfizer runs the PAXCESS program, which has offered Paxlovid at no cost to patients on Medicare, Medicaid, TRICARE, VA Community Care Network, or those who are uninsured. For people with commercial insurance, a co-pay savings card can reduce the cost to as little as $0, with a maximum savings benefit of $1,500 per prescription. At many pharmacies, an automatic discount brings the copay down to $25 before the savings card is even applied.

To get Paxlovid, you need a positive COVID-19 test and a prescription. Many telehealth services can evaluate you and send a prescription to your pharmacy the same day, which helps meet the narrow treatment window.